Prognostic biomarkers and next generation genomic sequencing
Prognostic biomarkers and next generation genomic sequencing
Bringing together the resources of Eastern and Western European institutes
Recent developments in neoadjuvant therapy
Highlights and goals of IMPAKT 2012
PI3K and the heterogeneity of small tumour breast cancer
Molecularly characterising triple negative breast cancer
Overcoming drug resistance and targeting critical pathways
Cancer genes differ in different parts of a tumour
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer
Endocrine therapy resistance and next generation sequencing
Molecular characterisation of breast cancer: the mutational landscape
Metabolism in malignant tumors: a new approach for treating breast cancer